Chronic oral sodium valproate given at high doses (100–200 mg/kg) suppressed the development of generalized clonic-tonic corasol (pentylenetetrazole) kindled convulsions in 100% of rats but prevented local clonic kindled convulsions in only 33–57%. At these doses, sodium valproate induced strong sedation. Combined chronic oral administration of Mesaton at the threshold dose of 0.2 mg/kg, inactive when give alone, and sodium valproate at the high doses of 100 and 200 mg/kg potentiated the anticonvulsant action of sodium valproate and prevented not only clonic-tonic kindled convulsions in 100% of rats, but also clonic kindled convulsions in 86–100% of rats, and also increased the anticonvulsant activity of valproate by factors of 1.7–1.9. These combinations of sodium valproate with Mesaton did not induce any sedative side effect. The mechanism of potentiation of the anticonvulsant effect and elimination of the sedative side effect of high-dose sodium valproate is based on stimulation of gastric mucosal afferents by Mesaton.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
S. E. Serdyuk and V. E. Gmiro, “Stimulation of gastric mucosal afferents by adrenaline potentiates the anticonvulsant but not the sedative action of diazepam in rats,” Ross. Fiziol. Zh., Vol. 98, No. 2, 236–241 (2012).
C. L. Deckers, Y. A. Hekster, A. Keyser, et al., “Adverse effects in epilepsy therapy. Wait and see or go for it?” Acta Neurol. Scand., 95, No. 4, 248–252 (1997).
W. Fischer and H. Kittner, “Influence of ethanol on the pentylenetetrazol-induced kindling in rats,” Neural Transm., 105, No. 10–12, 1129–1142 (1998).
R. N. Hughes, “Effects on open-field behavior of diazepam and buspirone alone and in combination with chronic caffeine,” Life Sci., 53, No. 15, 1217–1225 (1993).
G. M. Kennedy and S. D. Lhatoo, “CNS adverse events associated with antiepileptic drugs,” CNS Drugs, 22, No. 9, 739–760 (2008).
W. Loscher, “Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action,” Progr. Neurobiol., 58, No. 1, 31–59 (1999).
W. Loscher and I.E. Leppik, “Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs,” Epilepsy Res., 50, No. 1–2, 17–20 (2002).
J. Mehla, K. H. Reeta, P. Gupta, and Y. K. Gupta, “Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model,” Life Sci., 87, No. 19–22, 596–603 (2010).
K. Morimoto, M. Fahnestock, and R. J. Racine, “Kindling and status epilepticus models of epilepsy: rewiring the brain,” Progr. Neurobiol., 73, No. 1, 1–60 (2004).
O. Miyamoto, J. Pang, K. Sumitani, et al., “Mechanisms of the anti-ischemic effect of vagus nerve stimulation in the gerbil hippocampus,” Neuroreport, 14, No. 15, 1971–1974 (2003).
Y. Ohno, S. Ishihara, R. Terada, et al., “Anti-epileptogenic and anticonvulsant actions of levetiracetam in a pentylenetetrazole kindling model,” Epilepsy Res., 89, No. 2–3, 360–364 (2010).
K. Otsuki, K. Morimoto, K. Sato, et al., “Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats,” Epilepsy Res., 31, No. 2, 101–112 (1998).
E. Perucca, A. Aldenkamp, R. Tanis, and G. Krämer, “Role of valproate across the ages. Treatment of epilepsy in the elderly,” Acta. Neurol. Scand., Supplement, 184, 28–37 (2006).
S. Rao, K. R. Rajesh, and T. Joseph, “Effect of antiepileptic drugs valproic acid carbamazepine and ethosuccimide on exploratory behaviour in mice,” Indian Exp. Biol., 29, No. 2, 127–130 (1991).
G. Roks, C. L. Deckers, H. Meinardi, et al., “Effects of polytherapy compared with monotherapy in antiepileptic drugs: an animal study,” Pharmacol. Exp. Ther., 288, No. 2, 472–477 (1999).
P. A. Rutecki and B. E. Gidal, “Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs,” Epilepsy Behav., 3, No. 6S1, 24–31 (2002).
R. Talati, J. M. Scholle, O. P., Phung, et al., “Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review,” Pharmacotherapy, 32, No. 4, 314–322 (2012).
P. Tirassa, N. Costa, and L. Aloe, “CCK-8 prevents the development of kindling and regulates the GABA and NPY expression in the hippocampus of pentylenetetrazole (PTZ)-treated adult rats,” Neuropharmacology, 48, No. 5, 732–742 (2005).
H. C. Tomasiewicz, S. D. Mague, B. M. Cohen, and W. A. Carlezon, “Behavioral effects of short-term administration of lithium and valproic acid in rats,” Brain. Res., 1093, No. 1, 83–94 (2006).
R. D. Whitlow, A. Sacher, D. D. Loo, et al., “The anticonvulsant valproate increases the turnover rate of gamma-aminobutyric acid transporters,” J. Biol. Chem., 278, No. 20, 17,716–17,726 (2003).
X. H. Wu, M. P. Ding, Z. Zhu-Ge, et al., “Carnosine, a precursor of histidine ameliorates pentylenetetrazole-induced kindled seizures in rat,” Neurosci. Lett., 400, No. 1–2, 146–149 (2006).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 100, No. 1, pp. 96–104, January, 2014.
Rights and permissions
About this article
Cite this article
Serdyuk, S.E., Gmiro, V.E. & Veselkina, O.S. Stimulation of Gastric Mucosal Afferents with Mesaton Potentiates the Anticonvulsant and Eliminates the Sedative Actions of Sodium Valproate in Rats with Corasol Kindling. Neurosci Behav Physi 45, 795–799 (2015). https://doi.org/10.1007/s11055-015-0146-0
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-015-0146-0